CN102985091B - 使用抗微生物肽螯合化合物治疗皮肤疾病和异常的组合物和方法 - Google Patents
使用抗微生物肽螯合化合物治疗皮肤疾病和异常的组合物和方法 Download PDFInfo
- Publication number
- CN102985091B CN102985091B CN201180022095.1A CN201180022095A CN102985091B CN 102985091 B CN102985091 B CN 102985091B CN 201180022095 A CN201180022095 A CN 201180022095A CN 102985091 B CN102985091 B CN 102985091B
- Authority
- CN
- China
- Prior art keywords
- weight
- calculating
- skin
- antimicrobial peptide
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Description
Claims (50)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31016810P | 2010-03-03 | 2010-03-03 | |
US61/310,168 | 2010-03-03 | ||
PCT/US2011/026804 WO2011109469A1 (en) | 2010-03-03 | 2011-03-02 | Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102985091A CN102985091A (zh) | 2013-03-20 |
CN102985091B true CN102985091B (zh) | 2016-11-23 |
Family
ID=43805714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180022095.1A Active CN102985091B (zh) | 2010-03-03 | 2011-03-02 | 使用抗微生物肽螯合化合物治疗皮肤疾病和异常的组合物和方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US9629856B2 (zh) |
EP (1) | EP2542246A1 (zh) |
JP (1) | JP2013521300A (zh) |
KR (1) | KR20130018739A (zh) |
CN (1) | CN102985091B (zh) |
CA (1) | CA2790682C (zh) |
WO (1) | WO2011109469A1 (zh) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2498603B1 (en) | 2009-11-12 | 2016-07-13 | Signum Biosciences, Inc. | Use of anti-bacterial agents for the treatment of epithelial-related conditions |
JP2013521300A (ja) | 2010-03-03 | 2013-06-10 | ネオキュティス エスアー | 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法 |
AU2011273509A1 (en) * | 2010-06-30 | 2013-06-13 | Galderma Research & Development | Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor |
CA3043905A1 (en) * | 2011-01-07 | 2012-07-12 | Allergan, Inc. | Compositions comprising substituted benzaldehydes and use thereof for lightening skin or treating hyperpigmenation and hypermelanosis disorders |
EP2725904A4 (en) | 2011-06-28 | 2014-12-10 | Medicis Pharmaceutical Corp | HIGH-DOSE MUCOADHESIVE AQUEOUS METRONIZOUS MELTRONIDAZE GEL FORMULATIONS AND USE THEREOF FOR TREATING BACTERIAL VAGINOSIS |
FR2984126B1 (fr) * | 2011-12-20 | 2014-08-22 | Oreal | Polysaccharides sulfates agent antipelliculaire |
CN102614298B (zh) * | 2012-04-26 | 2013-10-30 | 肖连元 | 一种烫伤喷剂及其制备方法 |
DE102012214038A1 (de) * | 2012-08-08 | 2014-02-13 | Beiersdorf Ag | Verwendung von Wirkstoffkombinationen aus Harnstoff und Car-ni-tin und/oder einem oder mehreren Acyl-Carnitinen zur Behandlung und Prophylaxe von Neurodermitis sowie des diabetischen Fußes |
GEP20197049B (en) * | 2013-01-30 | 2019-12-10 | Boris Gorinshteyn | Compositions and methods for treating surface wounds |
EP2953950B1 (en) | 2013-02-11 | 2021-01-13 | The Regents of The University of California | Compositions and methods for treating neurodegenerative diseases |
FR3002452B1 (fr) * | 2013-02-28 | 2016-02-12 | Dermaconcept Jmc | Composition dermatologique antimicrobienne topique |
GB201304041D0 (en) | 2013-03-06 | 2013-04-17 | Water Jel Europ Llp | Treatment and prophylaxis of radiation dermatitis |
WO2014140890A2 (en) | 2013-03-13 | 2014-09-18 | Neocutis Sa | Peptides for skin rejuvenation and methods of using the same |
CN103263476B (zh) * | 2013-05-30 | 2015-05-13 | 广州市绿乔生物科技有限公司 | 一种用于减少刺激的复合抑菌剂 |
US9193852B2 (en) * | 2013-12-27 | 2015-11-24 | L'oreal | Stable aerated compositions |
CN104138397A (zh) * | 2014-01-13 | 2014-11-12 | 北京德默高科医药技术有限公司 | 一种预防和辅助治疗痔疮的组合物 |
HRP20220759T1 (hr) | 2014-02-11 | 2022-09-02 | Mitokinin, Inc. | Pripravci i postupci koji ih koriste za liječenje neurodegenerativne i mitohondrijske bolesti |
CN103830303B (zh) * | 2014-03-11 | 2016-03-02 | 北京德默高科医药技术有限公司 | 一种预防褥疮的组合物 |
CN103816089A (zh) * | 2014-03-11 | 2014-05-28 | 广州市洋林生物科技开发有限公司 | 一种皮肤粘膜抗菌液及皮肤粘膜抗菌湿巾 |
CN116515924A (zh) * | 2014-04-16 | 2023-08-01 | 青岛惠诺德生物科技有限公司 | 一种生物活性透明质酸片段、其生产方法、应用、制剂及含有该制剂的物品 |
FR3020570B1 (fr) * | 2014-04-30 | 2017-07-21 | Pierre Fabre Dermo-Cosmetique | Association d'un acide hyaluronique et d'un polysaccharide sulfate |
US10912811B1 (en) * | 2014-10-28 | 2021-02-09 | Felician Stancioiu | Composition for improving peripheral circulation and healing of hematomas |
WO2016090494A1 (en) * | 2014-12-12 | 2016-06-16 | Oceans Ltd. | Anti-microbial seaweed extracts, compositions and uses thereof |
GB2536072A (en) * | 2014-12-13 | 2016-09-07 | Berezin Anatoljevieh Vadim | Method for determination of the choice of the active ingredients of biological and chemical composition against infectious, oncology, skin diseases, which are |
WO2016137513A1 (en) * | 2015-02-27 | 2016-09-01 | Sutich Paul | Method and topical composition for the treatment of rosacea and skin erythema using selenium sulfide |
CN104761629B (zh) * | 2015-03-05 | 2017-12-26 | 大连理工大学 | 一种广谱高效抗微生物肽Pb‑CATH‑OH1及其基因、制备方法和应用 |
KR101721228B1 (ko) * | 2015-04-03 | 2017-03-30 | 사회복지법인 삼성생명공익재단 | 지방유래 줄기세포의 배양액을 유효성분으로 포함하는 발모촉진용 조성물 |
CN104721129A (zh) * | 2015-04-13 | 2015-06-24 | 上海东晟源日化有限公司 | 微乳化生物科技护肤品 |
CN106267168A (zh) * | 2015-05-12 | 2017-01-04 | 浙江海汇医疗科技有限公司 | 一种哺乳期妇女用乳头皲裂贴 |
CN104928081B (zh) * | 2015-05-26 | 2018-01-16 | 广州瑞嘉精细化工有限公司 | 一种抑螨除螨的马油和植物组合物及其在制皂中的用途 |
CN105254736B (zh) * | 2015-09-02 | 2018-06-08 | 大连理工大学 | 源于缅甸蟒的cathelicidin家族广谱抗微生物肽Pb-CATH4及其基因、制备与应用 |
CN105085647B (zh) * | 2015-09-07 | 2018-06-08 | 大连理工大学 | 天然抗感染抗氧化双功能肽Pb-CATH2及其基因与应用 |
US11702523B2 (en) | 2015-09-09 | 2023-07-18 | Bloom Holdings, Llc | Algae-derived flexible foam, and method of manufacturing the same |
KR102463131B1 (ko) * | 2015-09-30 | 2022-11-04 | (주)아모레퍼시픽 | Aha, 우레아, 및 니아신아마이드를 포함하는 각질 연화용 및 미백용 화장료 조성물 |
CN105287629B (zh) * | 2015-10-23 | 2018-04-17 | 四川农业大学 | 一种动物脱毛治疗剂的制备方法及其药用用途 |
WO2017087895A1 (en) | 2015-11-19 | 2017-05-26 | Bloom Holdings, Llc | Algae-derived flexible foam, and a method of manufacturing the same |
SI3389620T1 (sl) | 2015-12-15 | 2023-01-31 | Medicell Technologies, Llc | Sestavki, ki stimulirajo izvorne celice in postopki zdravljenja melazme |
ITUB20160058A1 (it) * | 2016-01-19 | 2017-07-19 | Farm S R L C U S | Composizione di un preparato per il trattamento delle punture di insetto con attivita’ vasocostrittiva, lenitiva, disinfiammante e disarrossante |
CN105622720B (zh) * | 2016-02-23 | 2020-09-08 | 浙江海洋学院 | 一种激活Nrf2-ARE通路的双髻鲨鱼肉抗氧化肽 |
CN106075334A (zh) * | 2016-06-23 | 2016-11-09 | 贝亲管理(上海)有限公司 | 一种组合物在辅助治疗婴儿湿疹中的用途 |
US11103544B2 (en) | 2016-12-30 | 2021-08-31 | Ann And Robert H. Lurie Children's Hospital Of Chicago | Application of honey and bacteria in methods of treating scalp conditions and hair conditions |
WO2018135813A1 (ko) * | 2017-01-19 | 2018-07-26 | 최성현 | 아토피성 질환을 포함하는 혈장 단백질의 삼출성 피부질환의 완화 및 치료용 패드 |
KR101859922B1 (ko) * | 2017-02-07 | 2018-05-21 | 주식회사 온코크로스 | 클로페네신을 포함하는 대장암 증식 및 전이 억제용 조성물 |
JP6900067B2 (ja) * | 2017-02-07 | 2021-07-07 | オンコクロス カンパニー,リミテッド | 癌の転移抑制および治療用組成物 |
CN106860401A (zh) * | 2017-02-09 | 2017-06-20 | 林映津 | 一种纯天然伤口修复剂 |
CN106943594A (zh) * | 2017-03-29 | 2017-07-14 | 西安交通大学 | Psoriasin抗体和LL‑37抗体在制备防治银屑病的药物中的应用 |
WO2018198039A1 (en) * | 2017-04-26 | 2018-11-01 | Dr. Reddy’S Laboratories Limited | Topical skin care compositions |
US11414419B2 (en) | 2017-06-21 | 2022-08-16 | Mitokinin, Inc. | Substituted purines for the treatment of neurodegenerative and mitochondrial diseases |
KR101983668B1 (ko) * | 2017-08-22 | 2019-05-29 | 건국대학교 산학협력단 | 그람 음성 박테리아에 대한 강한 항균 활성을 갖는 벌거숭이두더지쥐 유래의 항균성 폴리펩티드 및 이를 포함하는 약학 조성물 |
WO2019075263A2 (en) * | 2017-10-11 | 2019-04-18 | Illustris Pharmaceuticals, Inc. | METHODS AND COMPOSITIONS WITH TOPICAL ADMINISTRATION |
JP2021506971A (ja) | 2017-12-15 | 2021-02-22 | ターサス ファーマシューティカルズ, インコーポレイテッド | イソキサゾリン系寄生虫駆除剤及び眼瞼炎を治療する方法 |
CN111902876A (zh) | 2018-01-22 | 2020-11-06 | 癌症众生公司 | 用于进行虚拟试验的平台 |
EP3760232A4 (en) * | 2018-02-28 | 2021-05-05 | Sunsho Pharmaceutical Co.Ltd | COATING COMPOSITION AND CAPSULE USING A COATING COMPOSITION |
US20220249599A1 (en) * | 2018-03-13 | 2022-08-11 | Peptilogics, Inc. | Treatment of implants with engineered antimicrobial amphiphilic peptides |
CN108324926B (zh) * | 2018-03-23 | 2021-12-28 | 高志涛 | 干细胞提取物和抗菌肽的组合物及其用途 |
CN108403582A (zh) * | 2018-04-08 | 2018-08-17 | 北京皓尔生物科技有限公司 | 一种含抗菌肽的防痘、祛痘组合物及其应用 |
CN108294997A (zh) * | 2018-04-09 | 2018-07-20 | 青岛溯博生物技术有限公司 | 天然物质复合抗菌面膜粉、面膜及制备方法 |
WO2019204729A1 (en) * | 2018-04-19 | 2019-10-24 | Worcester Polytechnic Institute | Compositions and methods for skin treatments |
IT201800005585A1 (it) * | 2018-05-22 | 2019-11-22 | Composti per prevenire e trattare affezioni della pelle o della mucosa con componente infiammatoria | |
MX2021005979A (es) * | 2018-11-27 | 2021-07-06 | Colgate Palmolive Co | Composiciones de cuidado personal con multiples beneficios y metodos para estos. |
AU2019419387A1 (en) * | 2019-01-04 | 2021-07-22 | Dermata Therapeutics, Llc | Compositions and methods for the treatment of skin conditions |
FR3094637A1 (fr) * | 2019-04-04 | 2020-10-09 | Pierre Fabre Dermo-Cosmetique | Sulfate de dextran dans les dermatoses inflammatoires |
CN109916917B (zh) * | 2019-04-17 | 2021-07-13 | 湖北三环锻造有限公司 | 一种渗透探伤工艺 |
MX2022001707A (es) * | 2019-08-06 | 2022-03-11 | Natura Cosmeticos Sa | Composicion cosmetica topica, uso de la composicion y tonico para aplicacion facial. |
EP4032535A4 (en) * | 2019-09-20 | 2023-10-25 | University of Fukui | PHARMACEUTICAL COMPOSITION |
CN111388740B (zh) * | 2020-05-21 | 2021-09-10 | 南通大学 | 一种促伤口愈合敷料及其制备方法 |
KR102174084B1 (ko) * | 2020-06-01 | 2020-11-04 | 바이오닉랩 주식회사 | Afa 블루그린알지를 이용한 피부개선 및 피부재생용 화장품 조성물 |
DE102020211389A1 (de) | 2020-09-10 | 2022-03-10 | Beiersdorf Aktiengesellschaft | Wirkstoffhaltige Wundverschlusszubereitung |
CN112043817A (zh) * | 2020-09-14 | 2020-12-08 | 北京皓尔生物科技有限公司 | 一种抗螨虫的组合物及其应用 |
CN112220705B (zh) * | 2020-10-29 | 2021-07-06 | 芭芭多芦荟生物科技研究(广州)院 | 纯天然组分的保湿化妆品 |
WO2022099474A1 (zh) * | 2020-11-10 | 2022-05-19 | 南通优元美术图案设计有限公司 | 一种含有人参多糖包被层的胎盘间充质干细胞冻存管 |
CN112603993A (zh) * | 2020-12-19 | 2021-04-06 | 江苏诺瓦立医疗用品有限公司 | 一种基于壳聚糖治疗炎性痤疮的凝胶及其制备方法 |
EP4306100A1 (en) * | 2021-03-08 | 2024-01-17 | LG Household & Health Care Ltd. | Cosmetic composition comprising carnitine-salicylate as active ingredient |
CN113527428B (zh) * | 2021-09-17 | 2021-12-21 | 渤海水产育苗(山东)有限公司 | 海参肽及其应用和产品 |
CN114209809B (zh) * | 2021-12-24 | 2023-09-05 | 成都佩德生物医药有限公司 | 一种抗痤疮丙酸杆菌的联合用药物组合物及其应用 |
WO2023129413A1 (en) * | 2021-12-31 | 2023-07-06 | Ingredient Fusion, Llc | Molecular complexing method, formulation and manufacturing for enhanced nutrient delivery |
WO2023144701A1 (en) | 2022-01-28 | 2023-08-03 | Johnson & Johnson Consumer Inc. | Biomarkers predictive of atopic dermatitis |
WO2023194839A1 (en) | 2022-04-04 | 2023-10-12 | Donnelly | Window of opportunity skin treatment regimen and composition for preventing the onset of or treating atopic dermatitis |
US11730694B1 (en) | 2022-05-25 | 2023-08-22 | L'oreal | Hair coloring compositions and methods |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5872109A (en) * | 1995-02-07 | 1999-02-16 | Shiseido Company, Ltd. | Anti-inflammatory agent |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2798053A (en) | 1952-09-03 | 1957-07-02 | Goodrich Co B F | Carboxylic polymers |
US3238100A (en) * | 1963-07-23 | 1966-03-01 | American Maize Prod Co | Starch phosphate film composition and method of dressing wounds with same |
JPS5677294A (en) * | 1979-08-28 | 1981-06-25 | Maruko Seiyaku Kk | Aluminum compound substance of sucrose sulfate and dihydroxy aluminum allantoinate |
AU556817B2 (en) | 1982-02-03 | 1986-11-20 | Efamol Limited | Topical application of a lithium salt and dihomo-alpha- linolenic acid |
US4509949A (en) | 1983-06-13 | 1985-04-09 | The B. F. Goodrich Company | Water thickening agents consisting of copolymers of crosslinked acrylic acids and esters |
GB8401206D0 (en) | 1984-01-17 | 1984-02-22 | Allied Colloids Ltd | Polymers and aqueous solutions |
GB8414950D0 (en) | 1984-06-12 | 1984-07-18 | Allied Colloids Ltd | Cationic polyelectrolytes |
GB8531118D0 (en) | 1985-12-18 | 1986-01-29 | Allied Colloids Ltd | Copolymers |
US4912093A (en) | 1986-10-01 | 1990-03-27 | Marion Laboratories, Inc. | Use of synthetic sulfated saccharides to enhance wound healing |
GB8622797D0 (en) | 1986-09-22 | 1986-10-29 | Allied Colloids Ltd | Polymeric particles |
CA1329283C (en) | 1986-10-01 | 1994-05-03 | David Farrar | Water soluble polymeric compositions |
US4879282A (en) * | 1987-03-17 | 1989-11-07 | Saliba Jr Michael J | Medical application for heparin and related molecules |
US5916880A (en) * | 1987-12-21 | 1999-06-29 | Bukh Meditec A/S | Reduction of skin wrinkling using sulphated sugars |
DK505488D0 (da) * | 1987-12-21 | 1988-09-09 | Bar Shalom Daniel | Middel og anvendelse af samme |
GB8909095D0 (en) | 1989-04-21 | 1989-06-07 | Allied Colloids Ltd | Thickened aqueous compositions |
DE3922170A1 (de) * | 1989-07-06 | 1991-01-10 | Giulini Chemie | Neue salze von poly(alkylvinylether-maleinsaeureanhydrid) und damit hergestellte zahnprothesehaftmittel |
US5087445A (en) | 1989-09-08 | 1992-02-11 | Richardson-Vicks, Inc. | Photoprotection compositions having reduced dermal irritation |
JPH08502295A (ja) * | 1992-10-13 | 1996-03-12 | 大塚製薬株式会社 | 悪液質の治療およびil−6活性の阻害 |
SE9402531L (sv) | 1994-07-19 | 1996-01-20 | Medicarb Ab | Sårläkningsmedel |
JPH08277224A (ja) * | 1995-02-07 | 1996-10-22 | Shiseido Co Ltd | 抗炎症剤 |
FR2732221B1 (fr) | 1995-03-28 | 1997-04-25 | Oreal | Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue |
SE508760C2 (sv) | 1997-04-29 | 1998-11-02 | Medicarb Ab | Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur |
EP1079802B1 (en) | 1998-04-21 | 2007-02-28 | INFECTIO RECHERCHE Inc. | Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention |
CA2300082A1 (en) * | 1998-06-09 | 1999-12-16 | Ghen Corporation | Fixation inhibitors for helicobacter pylori |
US5952372A (en) | 1998-09-17 | 1999-09-14 | Mcdaniel; William Robert | Method for treating rosacea using oral or topical ivermectin |
JP2000178196A (ja) * | 1998-12-11 | 2000-06-27 | Seikagaku Kogyo Co Ltd | 新規ヒアルロニダーゼ阻害剤及び外用剤 |
US7816402B2 (en) * | 1999-03-19 | 2010-10-19 | Bioderm, Inc. | Compositions and methods for the treatment of skin |
US6444647B1 (en) | 1999-04-19 | 2002-09-03 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
GB9917092D0 (en) | 1999-07-22 | 1999-09-22 | Ml Lab Plc | Treatment of angiogenesis-dependent conditions |
FR2799369B1 (fr) * | 1999-10-08 | 2001-12-21 | Oreal | Association d'escine et de sulfate de dextran et son utilisation |
US20070009586A1 (en) | 2000-02-29 | 2007-01-11 | Cohen Kelman I | Wound dressings containing complexes of transition metals and alginate for elastase sequestering |
US6440465B1 (en) * | 2000-05-01 | 2002-08-27 | Bioderm, Inc. | Topical composition for the treatment of psoriasis and related skin disorders |
TWI320713B (zh) | 2001-06-01 | 2010-02-21 | Neochemir Inc | |
US6680062B2 (en) | 2001-10-05 | 2004-01-20 | Color Access, Inc. | Anti-irritating rosacea treatment |
JP2005060234A (ja) | 2003-08-08 | 2005-03-10 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
WO2006028863A1 (en) * | 2004-09-01 | 2006-03-16 | Nexmed Holdings, Inc. | Transdermal antiemesis delivery system, method and composition therefor |
FR2877565A1 (fr) | 2004-11-09 | 2006-05-12 | Oreal | Utilisation d'un sulfate de dextran de haut poids moleculaire comme agent apaisant |
EP1866036A2 (en) * | 2005-03-16 | 2007-12-19 | Procyte Corporation | Methods and compositions for preventing and treating aging or photodamaged skin |
CA2606255C (fr) | 2005-04-18 | 2013-10-08 | Sc Dicophar | Utilisation de la lecithine comme medicament dans le traitement du psoriasis |
EP1885865A4 (en) | 2005-05-12 | 2010-12-22 | Univ North Carolina | ENZYMATIC SYNTHESIS OF SULFATED POLYSACCHARIDES |
GB0517236D0 (en) | 2005-08-23 | 2005-09-28 | Ricardo Uk Ltd | A split carburettor with offset throttle plate |
KR101060634B1 (ko) | 2005-10-05 | 2011-08-31 | 에자끼구리고가부시키가이샤 | 인산화당을 함유한 피부외용제 |
EP2069377A4 (en) | 2006-09-27 | 2009-11-11 | Univ California | METHOD AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND SKIN FUNCTIONAL DISORDERS |
WO2008047779A1 (fr) * | 2006-10-17 | 2008-04-24 | Glycoscience Laboratories, Inc. | Agent thérapeutique ou prophylactique pour la dermatite atopique |
DE102006062438A1 (de) * | 2006-12-27 | 2008-07-03 | Henkel Kgaa | Kosmetische Zusammensetzungen zur Glättung und Straffung der Haut |
WO2008134430A1 (en) | 2007-04-24 | 2008-11-06 | Novelmed Therapeutics Inc. | Methods and compositions of inhibiting complement and cellular activation with dextran sulfate |
CA2694189A1 (en) | 2007-07-23 | 2009-01-29 | University Of Utah Research Foundation | Method for blocking ligation of the receptor for advanced glycation end-products (rage) |
US8802073B2 (en) * | 2007-11-15 | 2014-08-12 | Prelief Inc. | Methods and compositions for wound healing |
WO2009065116A1 (en) | 2007-11-16 | 2009-05-22 | Aspect Pharmaceuticals Llc | Compositions and methods for treating purpura |
JP2009143863A (ja) | 2007-12-14 | 2009-07-02 | Showa Denko Kk | 皮膚収斂剤 |
MX2010010904A (es) | 2008-04-04 | 2010-11-04 | Univ Utah Res Found | Eteres de glicosaminoglicosano semisinteticos alquilados, y metodos para elaborarlos y usarlos. |
US7932237B2 (en) * | 2008-05-15 | 2011-04-26 | Consejo Nacional De Investigaciones Cientificas Y Technicas (CONICET) | Pharmaceutical compositions for use in the treatment of wounds |
EP2201930A1 (en) * | 2008-12-23 | 2010-06-30 | Intendis GmbH | Hydrogel composition for the treatment of dermatological disorders |
US9326930B2 (en) | 2009-01-16 | 2016-05-03 | Neocutis S.A. | Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions |
JO3676B1 (ar) | 2009-07-27 | 2020-08-27 | Arc Medical Devices Inc | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها |
JP2013521300A (ja) | 2010-03-03 | 2013-06-10 | ネオキュティス エスアー | 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法 |
-
2011
- 2011-03-02 JP JP2012556198A patent/JP2013521300A/ja active Pending
- 2011-03-02 EP EP11707328A patent/EP2542246A1/en not_active Withdrawn
- 2011-03-02 WO PCT/US2011/026804 patent/WO2011109469A1/en active Application Filing
- 2011-03-02 KR KR1020127025690A patent/KR20130018739A/ko not_active Application Discontinuation
- 2011-03-02 CN CN201180022095.1A patent/CN102985091B/zh active Active
- 2011-03-02 US US13/038,524 patent/US9629856B2/en active Active
- 2011-03-02 CA CA2790682A patent/CA2790682C/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5872109A (en) * | 1995-02-07 | 1999-02-16 | Shiseido Company, Ltd. | Anti-inflammatory agent |
Non-Patent Citations (1)
Title |
---|
"Efficacy and Tolerance of a Topical Skin Care Regimen as an Adjunct to Treatment of Facial Rosacea;D. Gilbert, MD et al;《Cosmetic Dermatology》;20080930;第21卷(第9期);501-504 * |
Also Published As
Publication number | Publication date |
---|---|
EP2542246A1 (en) | 2013-01-09 |
KR20130018739A (ko) | 2013-02-25 |
CA2790682C (en) | 2020-11-24 |
CN102985091A (zh) | 2013-03-20 |
JP2013521300A (ja) | 2013-06-10 |
WO2011109469A1 (en) | 2011-09-09 |
US20110217249A1 (en) | 2011-09-08 |
CA2790682A1 (en) | 2011-09-09 |
US9629856B2 (en) | 2017-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102985091B (zh) | 使用抗微生物肽螯合化合物治疗皮肤疾病和异常的组合物和方法 | |
CN110191895A (zh) | 可用于处理和/或护理皮肤、毛发、指甲和/或粘膜的化合物 | |
KR20180123036A (ko) | 보습용 조성물 및 이의 용도 | |
WO2008140200A1 (en) | External compositions for the skin | |
CN109431873B (zh) | 一种修复舒缓皮肤炎症的组合物 | |
EP2961481B1 (fr) | Composition dermatologique antimicrobienne topique | |
CN105555285B (zh) | 用于促进生发及毛发生长的组合物 | |
KR20100039532A (ko) | 아토피 치료용 하이드로겔 조성물 및 이를 매트릭스로 사용하는 아토피 치료용 매트릭스 패치 | |
CN110279844A (zh) | 人工合成抗菌肽在制备抑菌消炎祛痘化妆品或外用药物制剂中的应用及抑菌消炎祛痘组合物 | |
WO2013190542A2 (en) | Topical compositions for the treatment of chronic inflammatory skin disease | |
WO2012042970A1 (ja) | アトピー性皮膚炎の予防剤または治療剤、および外用剤 | |
JP3172753B2 (ja) | 生体ヒアルロン酸合成促進剤 | |
AU2009256524B2 (en) | Compositions for treating rosacea comprising chitosan and a dicarboxylic acid | |
KR20170010499A (ko) | 달팽이 점액 발효여과물을 유효성분으로 하는 피부장벽 개선 및 높은 피부 흡수율을 갖는 화장료 조성물과 기능성 화장품 | |
ES2663574B1 (es) | Combinacion con funcion regenerativa de la funcion barrera de la piel | |
US20140357731A1 (en) | Healing cream | |
JP5937465B2 (ja) | コラーゲン産生促進剤、線維芽細胞増殖促進剤、しわ改善剤および皮膚外用剤 | |
JP7396585B2 (ja) | Tslp遺伝子発現抑制用、il-33遺伝子発現抑制用、又はフィラグリン産生促進用組成物 | |
WO2017188844A1 (ru) | Лечебно-косметическое средство при комплексном лечении дерматозов | |
Dua et al. | Preparation, physicochemical evaluation and antimicrobial potential of topical dosage forms containing natural anti-inflammatory agent, Curcuma longa | |
CN104840404A (zh) | 一种具有除臭功能的化妆品及其制备方法 | |
CN104829678B (zh) | 积雪草酸盐及其制备方法和用途 | |
ES2533200B1 (es) | Procedimiento para preparar extractos acuosos de plantas | |
CN117427006A (zh) | 包含青蒿提取物和油溶性成分的组合物及其应用 | |
CN117860605A (zh) | 用于保湿的组合物及其用途、化妆品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1182951 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: Merlin, Geneva, Switzerland Patentee after: Anteis S. A. Address before: Swiss Patentee before: Neocutis SA |
|
CP03 | Change of name, title or address | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1182951 Country of ref document: HK |